172 related articles for article (PubMed ID: 37047588)
1. A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity.
Praveen P; Wang C; Handley TNG; Wu H; Samuel CS; Bathgate RAD; Hossain MA
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047588
[TBL] [Abstract][Full Text] [Related]
2. Further Developments towards a Minimal Potent Derivative of Human Relaxin-2.
Handley TNG; Praveen P; Tailhades J; Wu H; Bathgate RAD; Hossain MA
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628851
[TBL] [Abstract][Full Text] [Related]
3. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1.
Hossain MA; Kocan M; Yao ST; Royce SG; Nair VB; Siwek C; Patil NA; Harrison IP; Rosengren KJ; Selemidis S; Summers RJ; Wade JD; Bathgate RAD; Samuel CS
Chem Sci; 2016 Jun; 7(6):3805-3819. PubMed ID: 30155023
[TBL] [Abstract][Full Text] [Related]
4. Single chain peptide agonists of relaxin receptors.
Praveen P; Kocan M; Valkovic A; Bathgate R; Hossain MA
Mol Cell Endocrinol; 2019 May; 487():34-39. PubMed ID: 30641102
[TBL] [Abstract][Full Text] [Related]
5. Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1.
Hossain MA; Praveen P; Noorzi NA; Wu H; Harrison IP; Handley T; Selemidis S; Samuel CS; Bathgate RAD
ACS Pharmacol Transl Sci; 2023 May; 6(5):842-853. PubMed ID: 37200817
[TBL] [Abstract][Full Text] [Related]
6. Synthetic covalently linked dimeric form of H2 relaxin retains native RXFP1 activity and has improved in vitro serum stability.
Nair VB; Bathgate RA; Separovic F; Samuel CS; Hossain MA; Wade JD
Biomed Res Int; 2015; 2015():731852. PubMed ID: 25685807
[TBL] [Abstract][Full Text] [Related]
7. Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxin.
Chan LJ; Rosengren KJ; Layfield SL; Bathgate RA; Separovic F; Samuel CS; Hossain MA; Wade JD
J Biol Chem; 2012 Nov; 287(49):41152-64. PubMed ID: 23024363
[TBL] [Abstract][Full Text] [Related]
8. Chimeric relaxin peptides highlight the role of the A-chain in the function of H2 relaxin.
Hossain MA; Wade JD; Bathgate RA
Peptides; 2012 May; 35(1):102-6. PubMed ID: 22414484
[TBL] [Abstract][Full Text] [Related]
9. Chemically synthesized dicarba H2 relaxin analogues retain strong RXFP1 receptor activity but show an unexpected loss of in vitro serum stability.
Hossain MA; Haugaard-Kedström LM; Rosengren KJ; Bathgate RA; Wade JD
Org Biomol Chem; 2015 Nov; 13(44):10895-903. PubMed ID: 26368576
[TBL] [Abstract][Full Text] [Related]
10. The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease.
Chen TY; Li X; Hung CH; Bahudhanapati H; Tan J; Kass DJ; Zhang Y
Mol Genet Genomic Med; 2020 Apr; 8(4):e1194. PubMed ID: 32100955
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective actions of relaxin.
Martin B; Romero G; Salama G
Mol Cell Endocrinol; 2019 May; 487():45-53. PubMed ID: 30625345
[TBL] [Abstract][Full Text] [Related]
12. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists.
Hu X; Myhr C; Huang Z; Xiao J; Barnaeva E; Ho BA; Agoulnik IU; Ferrer M; Marugan JJ; Southall N; Agoulnik AI
Biochemistry; 2016 Mar; 55(12):1772-83. PubMed ID: 26866459
[TBL] [Abstract][Full Text] [Related]
13. Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular Diseases.
Mallart S; Ingenito R; Bianchi E; Bresciani A; Esposito S; Gallo M; Magotti P; Monteagudo E; Orsatti L; Roversi D; Santoprete A; Tucci F; Veneziano M; Bartsch R; Boehm C; Brasseur D; Bruneau P; Corbier A; Froissant J; Gauzy-Lazo L; Gervat V; Marguet F; Menguy I; Minoletti C; Nicolas MF; Pasquier O; Poirier B; Raux A; Riva L; Janiak P; Strobel H; Duclos O; Illiano S
J Med Chem; 2021 Feb; 64(4):2139-2150. PubMed ID: 33555858
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a new potent and long-lasting single chain peptide agonist of RXFP1 in cells and in vivo translational models.
Illiano S; Poirier B; Minoletti C; Pasquier O; Riva L; Chenede X; Menguy I; Guillotel M; Prigent P; Le Claire S; Gillot F; Thill G; Lo Presti F; Corbier A; Le Bail JC; Grailhe P; Monteagudo E; Ingenito R; Bianchi E; Philippo C; Duclos O; Mallart S; Bathgate R; Janiak P
Sci Rep; 2022 Nov; 12(1):20435. PubMed ID: 36443381
[TBL] [Abstract][Full Text] [Related]
15. Understanding relaxin signalling at the cellular level.
Valkovic AL; Bathgate RA; Samuel CS; Kocan M
Mol Cell Endocrinol; 2019 May; 487():24-33. PubMed ID: 30592984
[TBL] [Abstract][Full Text] [Related]
16. The anti-fibrotic actions of relaxin are mediated through AT
Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
[TBL] [Abstract][Full Text] [Related]
17. Coatings Releasing the Relaxin Peptide Analogue B7-33 Reduce Fibrotic Encapsulation.
Welch NG; Mukherjee S; Hossain MA; Praveen P; Werkmeister JA; Wade JD; Bathgate RAD; Winkler DA; Thissen H
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45511-45519. PubMed ID: 31713411
[TBL] [Abstract][Full Text] [Related]
18. H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor.
Hossain MA; Man BC; Zhao C; Xu Q; Du XJ; Wade JD; Samuel CS
Biochemistry; 2011 Mar; 50(8):1368-75. PubMed ID: 21229994
[TBL] [Abstract][Full Text] [Related]
19. ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.
Kocan M; Sarwar M; Ang SY; Xiao J; Marugan JJ; Hossain MA; Wang C; Hutchinson DS; Samuel CS; Agoulnik AI; Bathgate RAD; Summers RJ
Sci Rep; 2017 Jun; 7(1):2968. PubMed ID: 28592882
[TBL] [Abstract][Full Text] [Related]
20. Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.
Xiao J; Huang Z; Chen CZ; Agoulnik IU; Southall N; Hu X; Jones RE; Ferrer M; Zheng W; Agoulnik AI; Marugan JJ
Nat Commun; 2013; 4():1953. PubMed ID: 23764525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
